More Healthcare Companies Go Public In 2020 Than Prior 5 Years

More Healthcare Companies Go Public In 2020 Than Prior 5 Years

According to a recent S&P Global Market Intelligence analysis, more healthcare companies went public in 2020 than they did in the past five years as the COVID-19 pandemic increased investor demand in the sector. In 2020, a total of 263 healthcare companies went public, up from 180 in 2019.

Play Quizzes 4

Get The Full Series in PDF

Get the entire 10-part series on Charlie Munger in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Q4 2020 hedge fund letters, conferences and more

Key highlights from the analysis include:

Voss Value Sees Plenty Of Opportunities In Cheap Small Caps [Exclusive]

investFor the first quarter of 2022, the Voss Value Fund returned -5.5% net of fees and expenses compared to a -7.5% total return for the Russell 2000 and a -4.6% total return for the S&P 500. According to a copy of the firm’s first-quarter letter to investors, a copy of which ValueWalk has been able Read More

  • Gross proceeds from IPO activity more than doubled year over year to $43.46 billion in 2020. In the last quarter of 2020 alone, companies raised $13.75 billion in IPO activity.
  • IPO activity in the healthcare sector remained robust during the closing months of 2020, with companies raising $13.75 billion during the last quarter.
  • San Diego-based Maravai LifeSciences Holdings Inc.'s IPO was the largest for the fourth quarter of 2020, raising about $1.86 billion in proceeds.
  • Among the 17 largest IPOs for the fourth quarter tracked, eight companies that went public during the period operate in the biotechnology space.

SNL Image

Healthcare Companies Going Public In Hong Kong

"I think investors in Asia recognize [biotech] is a vital industry for the future," Brad Loncar, a biotech investor and CEO of Loncar Investments, told Market Intelligence. Healthcare listings in Hong Kong, which is the largest market in Asia and the second-largest in the world for biotech IPOs, could be over 30 in 2021, Irene Chu, Hong Kong-based partner and head of new economy and life sciences at consultancy KPMG China, told Market Intelligence.

SNL Image

Goldman Sachs & Co. LLC and Goldman Sachs (Asia) LLC, which are part of Goldman Sachs Group Inc., acted as underwriters on the majority of the top-ranking healthcare IPOs in North America and Asia, respectively, during the fourth quarter of 2020. New York-based Credit Suisse Securities (USA) LLC and Jefferies LLC served as underwriting banks for IPOs by four companies each in North America. Among the Asian IPOs, JPMorgan Chase & Co.'s J.P. Morgan Securities PLC and J.P. Morgan Securities (Asia Pacific) Ltd. were underwriters for three offerings each.

SNL Image

A quarterly report by EY tracked 1,363 IPOs during 2020 worldwide, up 19% over 2019, while proceeds from the offerings totaled $268 billion, a year-over-year increase of 29%. Following the technology and industrials sectors, healthcare took the third spot in terms of IPOs, with 235 offerings totaling $50.4 billion in value.

Read the full article here by S&P Global Market Intelligence

Updated on

Jacob Wolinsky is the founder of, a popular value investing and hedge fund focused investment website. Jacob worked as an equity analyst first at a micro-cap focused private equity firm, followed by a stint at a smid cap focused research shop. Jacob lives with his wife and four kids in Passaic NJ. - Email: jacob(at) - Twitter username: JacobWolinsky - Full Disclosure: I do not purchase any equities anymore to avoid even the appearance of a conflict of interest and because at times I may receive grey areas of insider information. I have a few existing holdings from years ago, but I have sold off most of the equities and now only purchase mutual funds and some ETFs. I also own a few grams of Gold and Silver
Previous article The Top Of The Short Squeeze Bubble
Next article Warren Buffett And Charlie Munger On Short Selling

No posts to display